Serum levels of sex hormones and breast cancer risk in premenopausal women: a case–control study (USA)

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cancer Causes and Control

• Publication date

  2004-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1023/B:CACO.0000016574.79728.11PMID 14970734
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies.

  2002cited by this paper
• Endogenous hormones and the aetiology of breast cancer

  1999cited by this paper
• Reproducibility of plasma and urinary sex hormone levels in premenopausal women over a one-year period.

  1999cited by this paper
• Dietary supplements of dehydroepiandrosterone in relation to breast cancer risk

  1999cited by this paper
• A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey.

  1997influential reference
• Epidemiology of in situ and invasive breast cancer in women aged under 45.

  1996cited by this paper
• Epidemiology and prevention of breast cancer.

  1996cited by this paper
• 5-En-androstene-3 beta,17 beta-diol inhibits the growth of MCF-7 breast cancer cells when oestrogen receptors are blocked by oestradiol.

  1994cited by this paper
• Premenopausal estradiol levels and the risk of breast cancer: a new method of controlling for day of the menstrual cycle.

  1994cited by this paper
• A prospective study of endogenous hormones and breast cancer.

  1994influential reference
• Endogenous plasma sex hormones in pre- and postmenopausal women with breast cancer: results from a case-control study in Moscow.

  1992cited by this paper
• Relationship of prediagnostic serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing premenopausal breast cancer.

  1992cited by this paper
• Influence of dehydroepiandrosterone and 5-en-androstene-3 beta, 17 beta-diol on the growth of MCF-7 human breast cancer cells induced by 17 beta-estradiol.

  1992cited by this paper
• Serum steroids and prolactin during and after major surgical trauma

  1992cited by this paper
• Opposite effects of dehydroepiandrosterone on the growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas.

  1992cited by this paper
• Serum hormone levels in pre-menopausal Chinese women in Shanghai and white women in Los Angeles: results from two breast cancer case-control studies

  1990cited by this paper
• Biological effects of adrenal androgens on MCF-7 and BT-20 human breast cancer cells.

  1990cited by this paper
• Androgens and breast cancer in premenopausal women.

  1989cited by this paper
• Serum hormone levels in breast cancer patients and controls in Egypt and Great Britain. The Anglo-Egyptian Health Agreement Collaborative Study.

  1988cited by this paper
• The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer.

  1988cited by this paper
• Sex hormone levels in serum in relation to the development of breast cancer.

  1987influential reference
• High testosterone and low progesterone circulating levels in premenopausal patients with hyperplasia and cancer of the breast.

  1984cited by this paper
• Increased androgenic activity and breast cancer risk in premenopausal women.

  1984cited by this paper
• Abnormal 24-hr mean plasma concentrations of dehydroisoandrosterone and dehydroisoandrosterone sulfate in women with primary operable breast cancer.

  1981cited by this paper
• Estrogenic Effects of Physiological Concentrations of 5-Androstene-3β,17β-diol and Its Metabolism in MCF7 Human Breast Cancer Cells

  1981cited by this paper
• Twenty-four-hour preoperative endocrine profiles in women with benign and malignant breast disease.

  1977cited by this paper
• Simultaneous radioimmunoassay of plasma FSH, LH, progesterone, 17-hydroxyprogesterone, and estradiol-17 beta during the menstrual cycle.

  1972cited by this paper

• Hormone-associated dietary patterns and premenopausal breast cancer risk

  2025cites this paper
• Reduced Dehydroepiandrosterone-Sulfate Levels in the Mid-Luteal Subphase of the Menstrual Cycle: Implications to Women’s Health Research

  2022cites this paper
• Association of genetic polymorphisms with local steroid metabolism in human benign breasts.

  2021cites this paper
• Estrogen Biosynthesis in Breast Adipose Tissue during Menstrual Cycle in Women with 1 and without Breast Cancer 2

  2020cites this paper
• Cross talk between the glucocorticoid receptor and the progesterone receptor in modulation of progestin responses and HIV-1 infection

  2018cites this paper
• Estrogen biosynthesis in breast adipose tissue during menstrual cycle in women with and without breast cancer

  2018cites this paper
• Mechanisms of HIV Transmission in Depo-Provera Users: The Likely Role of Hypoestrogenism

  2016cites this paper
• Caracterización "in vitro e in vivo" de una nueva línea celular (IPC-366) de cáncer inflamatorio mamario canino (IMC): comparación con el cáncer de mama inflamatorio humano

  2016influential citation
• Sex Hormones, Oestrogen Receptor, Progesterone Receptor and Human Epithelial Receptor 2 Expressions in Pre and Postmenopausal Sub-Saharan African Women with Breast Cancer

  2016cites this paper
• Nipple Aspirate Fluid Hormone Concentrations and Breast Cancer Risk

  2016cites this paper
• The intracrinology of breast cancer.

  2015cites this paper
• Serum and Tissue Steroid Hormone Levels in Canine Mammary Tumours: Clinical and Prognostic Implications.

  2015cites this paper
• Steroid hormone secretion in inflammatory breast cancer cell lines

  2015cites this paper
• Complexities of androgen receptor signalling in breast cancer.

  2014influential citation
• Triple-negative breast cancer risk in women is increasing by the loss of estrogen supply or by defective estrogen signaling

  2014cites this paper
• Androgens in breast cancer 21 : 4 T 162 relevant levels in the circulation of women

  2014cites this paper
• Diverse pathomechanisms leading to the breakdown of cellular estrogen surveillance and breast cancer development: new therapeutic strategies

  2014cites this paper
• Dysparities between African-American and White American Women in Breast Cancer Incidence and Mortality

  2014influential citation
• Triple-negative breast cancer risk in women is defined by the defect of estrogen signaling: preventive and therapeutic implications

  2014cites this paper
• Effect of taxane‐based neoadjuvant chemotherapy on fibroglandular tissue volume and percent breast density in the contralateral normal breast evaluated by 3T MR

  2013cites this paper
• Urinary Estrogen Metabolites and Breast Cancer: A Combined Analysis of Individual Level Data

  2013cites this paper
• An Estrogen Model: The Relationship between Body Mass Index, Menopausal Status, Estrogen Replacement Therapy, and Breast Cancer Risk

  2012cites this paper
• Light deficiency confers breast cancer risk by endocrine disorders.

  2012cites this paper
• The Androgen-Excess Theory of Breast Cancer

  2012cites this paper
• Source-oriented Analysis of Air Pollutants and Cardiorespiratory Emergency Department Visits in St. Louis, MO, Using Speciated Elemental PM, Nonpolar Organics, and Source-apportioned PM Data

  2011cites this paper
• Breast cancer after hormone replacement therapy--does prognosis differ in perimenopausal and postmenopausal women?

  2011cites this paper
• Benefits and risks of ovarian function and reproduction for cancer development and prevention

  2011cites this paper
• Effects of Aerobic Exercise on Premenopausal Sex Hormone Levels: Results of the WISER Study, a Randomized Clinical Trial in Healthy, Sedentary, Eumenorrheic Women

  2011cites this paper
• American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of menopause.

  2011cites this paper
• Testosterone and risk of breast cancer: appraisal of existing evidence

  2010cites this paper
• Interaction between menopausal status and obesity in affecting breast cancer risk.

  2010cites this paper
• Serum sex hormone levels in pre- and postmenopausal breast cancer patients.

  2009cites this paper
• 2:16α-Hydroxyestrone Metabolite Ratio and Breast Cancer: A Combined Analysis

  2009cites this paper
• Aerobic Exercise, Estrogens, and Breast Cancer Risk

  2009cites this paper
• Intracrinology of breast microenvironment: hormonal status in nipple aspirate fluid and its relationship to breast cancer

  2009cites this paper
• 17-beta-Estradiol in relation to age at menarche and adult obesity in premenopausal women

  2009cites this paper
• Does the increase of endogenous steroid hormone levels also affect breast cancer risk in Chinese women? A case–control study in Chongqing, China

  2009cites this paper
• The Effects of Anthropometry and Angiogenesis on Breast Cancer Etiology

  2008cites this paper
• Relations between endogenous androgens and estrogens in postmenopausal women with suspected ischemic heart disease.

  2008cites this paper
• 17-beta-estradiol in relation to age at menarche and adult obesity in premenopausal women.

  2008cites this paper
• Migraine in Postmenopausal Women and the Risk of Invasive Breast Cancer

  2008cites this paper
• FRED HUTCHINSON CANCER RESEARCH CENTER CANCER SURVEILLANCE SYSTEM CUMULATIVE BIBLIOGRAPHY 1976 Publications

  2008cites this paper
• Influence of chemotherapy to hormonal levels in postmenopausal breast cancer patients.

  2008cites this paper
• Safety of testosterone treatment in postmenopausal women.

  2007cites this paper
• Drug Insight: breast cancer prevention and tissue-targeted hormone replacement therapy

  2007cites this paper
• Interrelationships between serum leptin, IGF-1, IGFBP3, C-peptide and prolactin and breast cancer risk in young women

  2006cites this paper
• American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of menopause.

  2006cites this paper
• Steroids and receptors in canine mammary cancer.

  2006cites this paper
• Risk of breast, ovary, and uterine corpus cancers among 85 268 women with AIDS

  2006cites this paper
• Are mammotropic hormones mainly permissive for the development of breast cancer?

  2006cites this paper
• Alcohol and dietary fibre intakes affect circulating sex hormones among premenopausal women

  2006cites this paper
• Menstrual cycle irregularities are associated with testosterone levels in healthy premenopausal women

  2006cites this paper
• Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.

  2006cites this paper
• Effects of Raloxifene on Circulating Prolactin and Estradiol Levels in Premenopausal Women at High Risk for Developing Breast Cancer

  2006cites this paper
• Estrogen and Progesterone Levels in Nipple Aspirate Fluid of Healthy Premenopausal Women: Relationship to Steroid Precursors and Response Proteins

  2006cites this paper
• The Association of Plasma DHEA and DHEA Sulfate with Breast Cancer Risk in Predominantly Premenopausal Women

  2006cites this paper
• TAS-108, a novel oral steroidal antiestrogenic agent, is a pure antagonist on estrogen receptor alpha and a partial agonist on estrogen receptor beta with low uterotrophic effect.

  2005cites this paper
• Mammacancer - en livsstilssygdom?

  2005cites this paper
• Measurement of total testosterone in women: comparison of a direct radioimmunoassay versus radioimmunoassay after organic solvent extraction and celite column partition chromatography.

  2005cites this paper
• The local hormonal environment and related biomarkers in the normal breast.

  2005cites this paper
• Breast cancer in African-American women.

  2005cites this paper
• TAS-108, a Novel Oral Steroidal Antiestrogenic Agent, Is a Pure Antagonist on Estrogen Receptor α and a Partial Agonist on Estrogen Receptor β with Low Uterotrophic Effect

  2005cites this paper
• Endogenous sex hormones and subsequent breast cancer in premenopausal women

  2004cites this paper